New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
12:38 EDTMYGN, MRK, BIRT, CVS, SSYS, USNA, GOOG, DDDOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday after ADP reported that dismal weather in January put a damper on private sector hiring. The market seemed indecisive in the opening 30 minutes of trading, but soon picked up downside momentum. The Nasdaq, which was down more than 1% early in the session, has trimmed its losses and the Dow has moved into positive ground, though just barely. ECONOMIC EVENTS: In the U.S., payroll company ADP reported that 175,000 service jobs were created in January, versus the expectations for 185,000 net new positions to have been added. The ISM services index rose to 54.0 in January from December's 53.0 reading, which was a bit ahead of expectations. COMPANY NEWS: Dow component Merck (MRK) advanced fractionally after the drug company’s quarterly results were generally in-line with expectations and it also announced three clinical collaboration agreements to evaluate its investigational anti-PD-1 immunotherapy… Shares of Google (GOOG) are advancing in a down market after the search giant reached a settlement with European Union regulators over antitrust allegations and research firm Bernstein hiked its price target on the stock to $1,500 from $1,350... CVS Caremark (CVS) announced plans to cease selling all tobacco products, including cigarettes, at all its locations starting October 1. MAJOR MOVERS: Among the notable gainers was multi-level-marketer USANA Health Sciences (USNA), which rose 17% after its results and guidance beat expectations. Also higher were shares of molecular diagnostic company Myriad Genetics (MYGN), which climbed over 11% after the company reported second quarter results that beat consensus expectations, raised its fiscal 2014 outlook, and announced the acquisition of Crescendo Bioscience. Among the noteworthy losers was 3D Systems (DDD), which plunged 16% after the maker of 3D printers and supplies lowered its profit outlook for the current fiscal year and guided to earnings next year below the consensus estimate. A number of 3D Systems’ peers fell as well, with the next biggest company in the sector, Stratasys (SSYS), also declining 3%. Also lower were shares of Actuate (BIRT), which slid about 17% after reporting earnings, announcing the acquisition of German software developer legodo ag and being downgraded at Drexel Hamilton. INDICES: Near midday, the Dow was up 13.12, or 0.08%, to 15,458.36; the Nasdaq was down 13.59, or 0.34%, to 4,017.93; and the S&P 500 was down 2.14, or 0.12%, to 1,753.06.
News For DDD;SSYS;MRK;GOOG;CVS;MYGN;USNA;BIRT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
December 8, 2014
17:30 EDTMRKMerck acquisition of Cubist could be a 'winner', Barron's says
Subscribe for More Information
17:30 EDTMRKMerck shares lower after reports of judge decision in Cubist/Hospira case
Subscribe for More Information
16:24 EDTMRKOn The Fly: Closing Wrap
Stocks on Wall Street were lower amid another drop in crude oil prices, which tumbled to five-year lows. The market opened slightly lower following weaker than expected data from China and Japan, with nothing of note on the domestic calendar to get buyers involved in the day’s activity. Near noon, the averages gained downside momentum and though the market pared its losses several times, it was never able to gain any steam to pull the indexes back into the green. ECONOMIC EVENTS: In the U.S., no major economic data was released. In Asia, Chinese exports rose 4.7% from a year earlier in November, which missed the consensus estimate for an 8% increase. Chinese imports fell 6.7% from the prior year last month, compared with projections for a 3.8% increase. Additionally, Japan's revised third quarter gross domestic product estimate showed the economy shrank more than initially thought, with growth contracting an annualized 1.9%. COMPANY NEWS: Shares of Cubist Pharmaceuticals (CBST) surged $26.24, or 35.29%, to $100.60 after Merck (MRK) agreed to acquire the maker of next-generation antibiotics for $102 per share in cash, or $8.4B and the assumption of $1.1B in debt. A number of other antibiotic makers also climbed, including Tetraphase (TTPH), which rose $2.45, or 8.82%, to $30.24, and Cempra (CEMP), which advanced $1.64, or 11.37%, to $16.06, while shares of Merck finished fractionally higher, adding 39c, or 0.63%, to $61.88 following the deal announcement. MAJOR MOVERS: Among the notable gainers following their presentations at the American Society of Hematology, or ASH, annual meeting were Calithera Biosciences (CALA), which gained $2.38, or 22.52%, to $12.95, and Acceleron Pharma (XLRN), which jumped $5.11, or 13.6%, to $42.67. Among the noteworthy losers was McDonald's (MCD), which fell $3.70, or 3.84%, to $92.61 after the Dow member reported a 2.2% decline in global same-restaurant sales in November. Additionally, the fast-food giant warned that its fourth quarter results would be hurt by its sales pressures, supplier issues in China and a stronger U.S. dollar. Also lower were shares of Liquidity Services (LQDT), which plunged $2.77, or 27.0%, to $7.49 after the company disclosed that Wal-Mart (WMT) had terminated a deal to provide it with surplus merchandise. INDEXES: The Dow fell 106.31, or 0.59%, to 17,852.48, the Nasdaq dropped 40.06, or 0.84%, to 4,740.69, and the S&P 500 slipped 15.06, or 0.73%, to 2,060.31.
16:24 EDTMRKAmgen initiates new combination trial for talimogene laherparepvec with KEYTRUDA
Subscribe for More Information
13:12 EDTMRKMerck paid full price but made good deal for Cubist, says UBS
Subscribe for More Information
12:40 EDTMRKOn The Fly: Midday Wrap
Subscribe for More Information
12:25 EDTMRKAntibiotic makers rise after Merck agrees to buy Cubist
Subscribe for More Information
11:30 EDTCVSLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
08:30 EDTMRKMerck says deals with Cubist includes $250M break-up fee clause
Subscribe for More Information
08:21 EDTMRKMerck says looked at all risks, including patent litgation, before Cubist deal
Subscribe for More Information
08:11 EDTMRKCubist volatility elevated into Merck acquiring for $8.4B in cash
Subscribe for More Information
08:08 EDTMRKMerck says about $9.5B of debt to be issued related to Cubist deal
Subscribe for More Information
07:54 EDTSSYSStratasys weakness creates attractive entry point, says UBS
Subscribe for More Information
07:35 EDTMRKAdvaxis reports FDA acceptance of IND application for ADXS-PSA combination trial
Subscribe for More Information
07:13 EDTMRKMerck to host conference call
Subscribe for More Information
07:01 EDTMRKMerck to acquire Cubist for $102 per share in cash, or $9.5B
Subscribe for More Information
07:00 EDTMRKMerck to acquire Cubist for $102 per share in cash
Subscribe for More Information
December 7, 2014
16:29 EDTMRKMerck in discussions to buy Cubist for $7B, Bloomberg reports
Subscribe for More Information
13:47 EDTGOOGGoogle could reach $634 in a year, Barron's says
Google shares look attractive at current levels and shares could reach $634.00 in a year, driven by stabilizing ad pricing, Barron's contends in a feature article. Reference Link
12:58 EDTMRKMerck presents KEYTRUDA data at ASH
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use